ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,287.60
0.00%
Dow Jones
41,938.45
-1.63%
Brent Oil
80.385
-0.29%
Bitcoin
93,318.67
-1.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Apache Corp. (A1PA34) Quote

Apache Corp.

Apache Corp. (A1PA34)

BOV
146.28
0.00
(0.00%)
Closed January 13 3:55PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
146.28
Bid
128.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
123.96 52 Week Range 185.94
Market Cap
44.867B
Previous Close
146.28
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
38
Shares Outstanding
306,719,000
Dividend Yield
2.84%
PE Ratio
2.54
Earnings Per Share (EPS)
9.31
Revenue
8.28B
Net Profit
2.86B

About Apache Corp.

Sector
Crude Petroleum & Natural Gs
Industry
Crude Petroleum & Natural Gs
Website
www.apacorp.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Apache Corp. is listed in the Crude Petroleum & Natural Gs sector of the Brazil Bovespa Exchange with ticker A1PA34. The last closing price for Apache was R$146.28. Over the last year, Apache shares have traded in a share price range of R$ 123.96 to R$ 185.94.

Apache currently has 306,719,000 shares outstanding. The market capitalization of Apache is R$44.87 billion. Apache has a price to earnings ratio (PE ratio) of 2.54.

Ask ADVFN Intelligence (AI)

A1PA34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.631.83083884441143.65147143.656146.50647059DR
416.2812.5230769231130147124.545139.13787879DR
122.361.63979988883143.92147123.9638131.18190778DR
26-10.52-6.70918367347156.8185.94123.9647144.72817021DR
52-13.68-8.55213803451159.96185.94123.9656150.45757227DR
156-21.39-12.7572016461167.67253.25123.96187188.75833088DR
26019.3915.2809520057126.89253.2522.74674108.79916928DR

A1PA34 - Frequently Asked Questions (FAQ)

What is the current Apache share price?
The current share price of Apache is R$ 146.28
How many Apache shares are in issue?
Apache has 306,719,000 shares in issue
What is the market cap of Apache?
The market capitalisation of Apache is BRL 44.87B
What is the 1 year trading range for Apache share price?
Apache has traded in the range of R$ 123.96 to R$ 185.94 during the past year
What is the PE ratio of Apache?
The price to earnings ratio of Apache is 2.54
What is the cash to sales ratio of Apache?
The cash to sales ratio of Apache is 0.88
What is the reporting currency for Apache?
Apache reports financial results in USD
What is the latest annual turnover for Apache?
The latest annual turnover of Apache is USD 8.28B
What is the latest annual profit for Apache?
The latest annual profit of Apache is USD 2.86B
What is the registered address of Apache?
The registered address for Apache is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Apache website address?
The website address for Apache is www.apacorp.com
Which industry sector does Apache operate in?
Apache operates in the CRUDE PETROLEUM & NATURAL GS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMAR11Lojas Marisa S.A.
R$ 0.69
(13.11%)
4.1k
IFCM3Infracommerce Caxaas S.A.
R$ 0.09
(12.50%)
4.88M
MWET4Wetzel Sa (ex Metalurgica Wetzel Sa)
R$ 10.80
(8.65%)
3k
FICT3Fictor Alimentos S.A.
R$ 3.13
(7.93%)
80k
OIBR3Oi
R$ 1.47
(6.52%)
8.74M
GPAR3Companhia Celg de Participacoes Celgpar
R$ 31.40
(-33.19%)
100
CAML3Camil Alimentos, S.A.
R$ 4.91
(-14.46%)
6.51M
PSVM11PORTO SUDESTE VM SA
R$ 4.46
(-10.44%)
100
IGTI4Iguatemi S.A.
R$ 7.50
(-8.54%)
700
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.43
(-8.16%)
1.15M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.20
(-2.65%)
48.51M
BBDC4Bco Bradesco Sa
R$ 11.18
(-1.24%)
46.31M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.94
(0.271444%)
40.33M
ABEV3Ambev SA
R$ 11.16
(-2.11%)
31.28M
VALE3Vale SA
R$ 51.52
(0.57%)
25.83M

Discussion

View Full Feed
sunspotter sunspotter 14 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 25 minutes ago
Marc loved your ides
tinojax tinojax 26 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 28 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 44 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 44 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 45 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 46 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 53 minutes ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 56 minutes ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.
Shawonsarker84 Shawonsarker84 1 hour ago
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 1 hour ago
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 1 hour ago
Oh noooooo.....
FNMA
StockItOut StockItOut 1 hour ago
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 2 hours ago
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL

Your Recent History

BOV
A1PA34
Apache
LSE
62AA
Westp. Sec 24
LSE
79VX
Mitsu Hc Cap 23
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads